Sangeetha Yoganathan,Robyn Whitney,Maya Thomas,Sumita Danda,Akbar Mohamed Chettali,Asuri N. Prasad,Sali M. K. Farhan,Daad AlSowat,Musaad Abukhaled,Hesham Aldhalaan,Vykuntaraju K. Gowda,Uddhava V. Kinhal,Arun Y. Bylappa,Ramesh Konanki,Lokesh Lingappa,Bindu Madhavi Parchuri,Juan P. Appendino,Morris H. Scantlebury,Jessie Cunningham,Aristides Hadjinicolaou,Christelle Moufawad El Achkar,Mahesh Kamate,Ramshekhar N. Menon,Manna Jose,Gillian Riordan,Lakshminarayanan Kannan,Vivek Jain,Ranjith Kumar Manokaran,Vann Chau,Elizabeth J. Donner,Gregory Costain,Berge A. Minassian,Puneet Jain,Uddhava V. Kinhal,Bindu Madhavi Parchuri,Christelle Moufawad El Achkar

Abstract:Objective KCTD7‐related progressive myoclonic epilepsy (PME) is a rare autosomal‐recessive disorder. This study aimed to describe the clinical details and genetic variants in a large international cohort. Methods Families with molecularly confirmed diagnoses of KCTD7‐related PME were identified through international collaboration. Furthermore, a systematic review was done to identify previously reported cases. Salient demographic, epilepsy, treatment, genetic testing, electroencephalographic (EEG), and imaging‐related variables were collected and summarized. Results Forty‐two patients (36 families) were included. The median age at first seizure was 14 months (interquartile range = 11.75–22.5). Myoclonic seizures were frequently the first seizure type noted (n = 18, 43.9%). EEG and brain magnetic resonance imaging findings were variable. Many patients exhibited delayed development with subsequent progressive regression (n = 16, 38.1%). Twenty‐one cases with genetic testing available (55%) had previously reported variants in KCTD7, and 17 cases (45%) had novel variants in KCTD7 gene. Six patients died in the cohort (age range = 1.5–21 years). The systematic review identified 23 eligible studies and further identified 59 previously reported cases of KCTD7‐related disorders from the literature. The phenotype for the majority of the reported cases was consistent with a PME (n = 52, 88%). Other reported phenotypes in the literature included opsoclonus myoclonus ataxia syndrome (n = 2), myoclonus dystonia (n = 2), and neuronal ceroid lipofuscinosis (n = 3). Eight published cases died over time (14%, age range = 3–18 years). Significance This study cohort and systematic review consolidated the phenotypic spectrum and natural history of KCTD7‐related disorders. Early onset drug‐resistant epilepsy, relentless neuroregression, and severe neurological sequalae were common. Better understanding of the natural history may help future clinical trials.

Progressive myoclonus epilepsy and ceroidolipofuscinosis 14: The multifaceted phenotypic spectrum of KCTD7-related disorders

KCTD7-related progressive myoclonus epilepsy

Compound heterozygous KCTD7 variants in progressive myoclonus epilepsy

KCTD7 Deficiency Defines a Distinct Neurodegenerative Disorder with a Conserved Autophagy‐lysosome Defect

A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system

KCTD7‐related progressive myoclonic epilepsy: Report of 42 cases and review of literature

Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene

Linkage Analysis and Exome Sequencing Identify a Novel Mutation in KCTD7 in Patients with Progressive Myoclonus Epilepsy with Ataxia.

Progressive myoclonic epilepsy-associated gene KCTD7 is a regulator of potassium conductance in neurons

Kctd7 deficiency induces myoclonic seizures associated with Purkinje cell death and microvascular defects

Mutation of a potassium channel-related gene in progressive myoclonic epilepsy

Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlations

Nonsyndromic Early-Onset Epileptic Encephalopathies: Two Novel KCTD7 Pathogenic Variants and a Literature Review

KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties

Exome sequencing identifies compound heterozygous KCTD7 mutations in a girl with progressivemyoclonus epilepsy

Novel mutation in potassium channel related gene KCTD7 and progressive myoclonic epilepsy

Lysosomal Dysfunction, Autophagic Defects, and CLN5 Accumulation Underlie the Pathogenesis of KCTD7-mutated Neuronal Ceroid Lipofuscinoses

A Novel Mutation in KCDT7 Gene in an Indian Girl With Progressive Myoclonus Epilepsy

Clinical and neurophysiological features of familial cortical myoclonic tremor with epilepsy.

Alternating Hemiplegia and Epilepsia Partialis Continua: A new phenotype for a novel compound TBC1D24 mutation

The involvement of Purkinje cells in progressive myoclonic epilepsy: Focus on neuronal ceroid lipofuscinosis